Is quantum computing the next big thing? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by ARK Chief Futurist Brett Winton to discuss the latest advancements in quantum computing and AI drug discovery. They discuss Google's recent quantum chip announcement, the challenges of scaling quantum technology, and the potential applications in drug discovery. The conversation shifts to the partnership between GlaxoSmithKline and Relation Therapeutics, highlighting the promise of AI in revolutionizing drug development processes, reducing costs, and improving efficiency. The episode concludes with insights on the future of drug development and the potential for significant market changes in the pharmaceutical industry.
If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.
Key Points From
|
San Antonio Spurs superstar Victor Wemba...
Former Naval CENTCOM Commander Vice Adm....
Treasury Secretary Scott Bessent address...
----------------------------------------...
Fox News contributor Jonathan Morris joi...
FTC Chairman Andrew Ferguson addresses f...
Sponsored by Navy Federal Credit Union ...
Montblanc’s fountain pen, the Meisterstü...
----------------------------------------...
Sony enters the RGB LED backlighting spa...
----------------------------------------...
<2026年5月21日(木)開催> ▼ハッチの米国株マーケットセミナー(口座保...
Discussing pay has long been considered ...